Precision non-implantable neuromodulation therapies: a perspective for the depressed brain
Current first-line treatments for major depressive disorder (MDD) include pharmacotherapy and cognitive-behavioral therapy. However, one-third of depressed patients do not achieve remission after multiple medication trials, and psychotherapy can be costly and time-consuming. Although non-implantable...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Associação Brasileira de Psiquiatria
2020
|
| _version_ | 1826275625558605824 |
|---|---|
| author | Borrione, L Bellini, H Boralli Razza, L Avila, AG Baeken, C Brem, A-K Busatto, G Carvalho, AF Chekroud, A Daskalakis, ZJ Deng, Z-D Downar, J Gattaz, W Loo, C Lotufo, PA Martin, MDGM McClintock, SM O'Shea, J Padberg, F Passos, IC Salum, GA Vanderhasselt, M-A Fraguas, R Benseñor, I Valiengo, L Brunoni, AR |
| author_facet | Borrione, L Bellini, H Boralli Razza, L Avila, AG Baeken, C Brem, A-K Busatto, G Carvalho, AF Chekroud, A Daskalakis, ZJ Deng, Z-D Downar, J Gattaz, W Loo, C Lotufo, PA Martin, MDGM McClintock, SM O'Shea, J Padberg, F Passos, IC Salum, GA Vanderhasselt, M-A Fraguas, R Benseñor, I Valiengo, L Brunoni, AR |
| author_sort | Borrione, L |
| collection | OXFORD |
| description | Current first-line treatments for major depressive disorder (MDD) include pharmacotherapy and cognitive-behavioral therapy. However, one-third of depressed patients do not achieve remission after multiple medication trials, and psychotherapy can be costly and time-consuming. Although non-implantable neuromodulation (NIN) techniques such as transcranial magnetic stimulation, transcranial direct current stimulation, electroconvulsive therapy, and magnetic seizure therapy are gaining momentum for treating MDD, the efficacy of non-convulsive techniques is still modest, whereas use of convulsive modalities is limited by their cognitive side effects. In this context, we propose that NIN techniques could benefit from a precision-oriented approach. In this review, we discuss the challenges and opportunities in implementing such a framework, focusing on enhancing NIN effects via a combination of individualized cognitive interventions, using closed-loop approaches, identifying multimodal biomarkers, using computer electric field modeling to guide targeting and quantify dosage, and using machine learning algorithms to integrate data collected at multiple biological levels and identify clinical responders. Though promising, this framework is currently limited, as previous studies have employed small samples and did not sufficiently explore pathophysiological mechanisms associated with NIN response and side effects. Moreover, cost-effectiveness analyses have not been performed. Nevertheless, further advancements in clinical trials of NIN could shift the field toward a more “precision-oriented” practice. |
| first_indexed | 2024-03-06T23:01:37Z |
| format | Journal article |
| id | oxford-uuid:6252936b-42f9-4365-a5c1-08ab065a65a1 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T23:01:37Z |
| publishDate | 2020 |
| publisher | Associação Brasileira de Psiquiatria |
| record_format | dspace |
| spelling | oxford-uuid:6252936b-42f9-4365-a5c1-08ab065a65a12022-03-26T18:05:36ZPrecision non-implantable neuromodulation therapies: a perspective for the depressed brainJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:6252936b-42f9-4365-a5c1-08ab065a65a1EnglishSymplectic ElementsAssociação Brasileira de Psiquiatria2020Borrione, LBellini, HBoralli Razza, LAvila, AGBaeken, CBrem, A-KBusatto, GCarvalho, AFChekroud, ADaskalakis, ZJDeng, Z-DDownar, JGattaz, WLoo, CLotufo, PAMartin, MDGMMcClintock, SMO'Shea, JPadberg, FPassos, ICSalum, GAVanderhasselt, M-AFraguas, RBenseñor, IValiengo, LBrunoni, ARCurrent first-line treatments for major depressive disorder (MDD) include pharmacotherapy and cognitive-behavioral therapy. However, one-third of depressed patients do not achieve remission after multiple medication trials, and psychotherapy can be costly and time-consuming. Although non-implantable neuromodulation (NIN) techniques such as transcranial magnetic stimulation, transcranial direct current stimulation, electroconvulsive therapy, and magnetic seizure therapy are gaining momentum for treating MDD, the efficacy of non-convulsive techniques is still modest, whereas use of convulsive modalities is limited by their cognitive side effects. In this context, we propose that NIN techniques could benefit from a precision-oriented approach. In this review, we discuss the challenges and opportunities in implementing such a framework, focusing on enhancing NIN effects via a combination of individualized cognitive interventions, using closed-loop approaches, identifying multimodal biomarkers, using computer electric field modeling to guide targeting and quantify dosage, and using machine learning algorithms to integrate data collected at multiple biological levels and identify clinical responders. Though promising, this framework is currently limited, as previous studies have employed small samples and did not sufficiently explore pathophysiological mechanisms associated with NIN response and side effects. Moreover, cost-effectiveness analyses have not been performed. Nevertheless, further advancements in clinical trials of NIN could shift the field toward a more “precision-oriented” practice. |
| spellingShingle | Borrione, L Bellini, H Boralli Razza, L Avila, AG Baeken, C Brem, A-K Busatto, G Carvalho, AF Chekroud, A Daskalakis, ZJ Deng, Z-D Downar, J Gattaz, W Loo, C Lotufo, PA Martin, MDGM McClintock, SM O'Shea, J Padberg, F Passos, IC Salum, GA Vanderhasselt, M-A Fraguas, R Benseñor, I Valiengo, L Brunoni, AR Precision non-implantable neuromodulation therapies: a perspective for the depressed brain |
| title | Precision non-implantable neuromodulation therapies: a perspective for the depressed brain |
| title_full | Precision non-implantable neuromodulation therapies: a perspective for the depressed brain |
| title_fullStr | Precision non-implantable neuromodulation therapies: a perspective for the depressed brain |
| title_full_unstemmed | Precision non-implantable neuromodulation therapies: a perspective for the depressed brain |
| title_short | Precision non-implantable neuromodulation therapies: a perspective for the depressed brain |
| title_sort | precision non implantable neuromodulation therapies a perspective for the depressed brain |
| work_keys_str_mv | AT borrionel precisionnonimplantableneuromodulationtherapiesaperspectiveforthedepressedbrain AT bellinih precisionnonimplantableneuromodulationtherapiesaperspectiveforthedepressedbrain AT borallirazzal precisionnonimplantableneuromodulationtherapiesaperspectiveforthedepressedbrain AT avilaag precisionnonimplantableneuromodulationtherapiesaperspectiveforthedepressedbrain AT baekenc precisionnonimplantableneuromodulationtherapiesaperspectiveforthedepressedbrain AT bremak precisionnonimplantableneuromodulationtherapiesaperspectiveforthedepressedbrain AT busattog precisionnonimplantableneuromodulationtherapiesaperspectiveforthedepressedbrain AT carvalhoaf precisionnonimplantableneuromodulationtherapiesaperspectiveforthedepressedbrain AT chekrouda precisionnonimplantableneuromodulationtherapiesaperspectiveforthedepressedbrain AT daskalakiszj precisionnonimplantableneuromodulationtherapiesaperspectiveforthedepressedbrain AT dengzd precisionnonimplantableneuromodulationtherapiesaperspectiveforthedepressedbrain AT downarj precisionnonimplantableneuromodulationtherapiesaperspectiveforthedepressedbrain AT gattazw precisionnonimplantableneuromodulationtherapiesaperspectiveforthedepressedbrain AT looc precisionnonimplantableneuromodulationtherapiesaperspectiveforthedepressedbrain AT lotufopa precisionnonimplantableneuromodulationtherapiesaperspectiveforthedepressedbrain AT martinmdgm precisionnonimplantableneuromodulationtherapiesaperspectiveforthedepressedbrain AT mcclintocksm precisionnonimplantableneuromodulationtherapiesaperspectiveforthedepressedbrain AT osheaj precisionnonimplantableneuromodulationtherapiesaperspectiveforthedepressedbrain AT padbergf precisionnonimplantableneuromodulationtherapiesaperspectiveforthedepressedbrain AT passosic precisionnonimplantableneuromodulationtherapiesaperspectiveforthedepressedbrain AT salumga precisionnonimplantableneuromodulationtherapiesaperspectiveforthedepressedbrain AT vanderhasseltma precisionnonimplantableneuromodulationtherapiesaperspectiveforthedepressedbrain AT fraguasr precisionnonimplantableneuromodulationtherapiesaperspectiveforthedepressedbrain AT bensenori precisionnonimplantableneuromodulationtherapiesaperspectiveforthedepressedbrain AT valiengol precisionnonimplantableneuromodulationtherapiesaperspectiveforthedepressedbrain AT brunoniar precisionnonimplantableneuromodulationtherapiesaperspectiveforthedepressedbrain |